Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 537

    1.

    CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment.

    Vahdat S, Oermann EK, Collins SP, Yu X, Abedalthagafi M, Debrito P, Suy S, Yousefi S, Gutierrez CJ, Chang T, Banovac F, Anderson ED, Esposito G, Collins BT.

    J Hematol Oncol. 2010 Feb 4;3:6.

    PMID:
    20132557
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy.

    Burdick MJ, Stephans KL, Reddy CA, Djemil T, Srinivas SM, Videtic GM.

    Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1033-9. Epub 2010 May 14.

    PMID:
    20472359
    [PubMed - indexed for MEDLINE]
    3.

    Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancer.

    Collins BT, Vahdat S, Erickson K, Collins SP, Suy S, Yu X, Zhang Y, Subramaniam D, Reichner CA, Sarikaya I, Esposito G, Yousefi S, Jamis-Dow C, Banovac F, Anderson ED.

    J Hematol Oncol. 2009 Jan 17;2:1.

    PMID:
    19149899
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    Revisiting the prognostic value of preoperative (18)F-fluoro-2-deoxyglucose ( (18)F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC).

    Agarwal M, Brahmanday G, Bajaj SK, Ravikrishnan KP, Wong CY.

    Eur J Nucl Med Mol Imaging. 2010 Apr;37(4):691-8. Epub 2009 Nov 14.

    PMID:
    19915840
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.

    Ashamalla H, Rafla S, Parikh K, Mokhtar B, Goswami G, Kambam S, Abdel-Dayem H, Guirguis A, Ross P, Evola A.

    Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1016-23. Epub 2005 Jun 24.

    PMID:
    15979817
    [PubMed - indexed for MEDLINE]
    6.

    FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer.

    Hoopes DJ, Tann M, Fletcher JW, Forquer JA, Lin PF, Lo SS, Timmerman RD, McGarry RC.

    Lung Cancer. 2007 May;56(2):229-34. Epub 2007 Mar 13.

    PMID:
    17353064
    [PubMed - indexed for MEDLINE]
    7.

    Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning.

    Hong R, Halama J, Bova D, Sethi A, Emami B.

    Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):720-6.

    PMID:
    17293230
    [PubMed - indexed for MEDLINE]
    8.

    18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer.

    Higashi K, Ueda Y, Arisaka Y, Sakuma T, Nambu Y, Oguchi M, Seki H, Taki S, Tonami H, Yamamoto I.

    J Nucl Med. 2002 Jan;43(1):39-45.

    PMID:
    11801701
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma.

    Hoang JK, Hoagland LF, Coleman RE, Coan AD, Herndon JE 2nd, Patz EF Jr.

    J Clin Oncol. 2008 Mar 20;26(9):1459-64.

    PMID:
    18349396
    [PubMed - indexed for MEDLINE]
    10.

    18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?

    Biehl KJ, Kong FM, Dehdashti F, Jin JY, Mutic S, El Naqa I, Siegel BA, Bradley JD.

    J Nucl Med. 2006 Nov;47(11):1808-12.

    PMID:
    17079814
    [PubMed - indexed for MEDLINE]
    Free Article
    11.

    Predictive value of 18F-fluorodeoxyglucose uptake by positron emission tomography for non-small cell lung cancer patients treated with radical radiotherapy.

    Ikushima H, Dong L, Erasmus J, Allen P, McAleer MF, Zhuang Y, Sasaki R, Komaki R.

    J Radiat Res (Tokyo). 2010;51(4):465-71. Epub 2010 May 28.

    PMID:
    20508373
    [PubMed - indexed for MEDLINE]
    Free Article
    12.

    Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection.

    Downey RJ, Akhurst T, Gonen M, Vincent A, Bains MS, Larson S, Rusch V.

    J Clin Oncol. 2004 Aug 15;22(16):3255-60.

    PMID:
    15310769
    [PubMed - indexed for MEDLINE]
    13.

    Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.

    Bradley J, Thorstad WL, Mutic S, Miller TR, Dehdashti F, Siegel BA, Bosch W, Bertrand RJ.

    Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):78-86.

    PMID:
    15093902
    [PubMed - indexed for MEDLINE]
    14.

    Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.

    Nestle U, Kremp S, Schaefer-Schuler A, Sebastian-Welsch C, Hellwig D, Rübe C, Kirsch CM.

    J Nucl Med. 2005 Aug;46(8):1342-8.

    PMID:
    16085592
    [PubMed - indexed for MEDLINE]
    Free Article
    15.

    Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.

    Deniaud-Alexandre E, Touboul E, Lerouge D, Grahek D, Foulquier JN, Petegnief Y, Grès B, El Balaa H, Keraudy K, Kerrou K, Montravers F, Milleron B, Lebeau B, Talbot JN.

    Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1432-41. Epub 2005 Aug 25.

    PMID:
    16125870
    [PubMed - indexed for MEDLINE]
    16.

    Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project.

    Berghmans T, Dusart M, Paesmans M, Hossein-Foucher C, Buvat I, Castaigne C, Scherpereel A, Mascaux C, Moreau M, Roelandts M, Alard S, Meert AP, Patz EF Jr, Lafitte JJ, Sculier JP; European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project.

    J Thorac Oncol. 2008 Jan;3(1):6-12. Review.

    PMID:
    18166834
    [PubMed - indexed for MEDLINE]
    17.

    Defining a radiotherapy target with positron emission tomography.

    Black QC, Grills IS, Kestin LL, Wong CY, Wong JW, Martinez AA, Yan D.

    Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1272-82.

    PMID:
    15519800
    [PubMed - indexed for MEDLINE]
    19.

    18F-FDG uptake as a biologic factor predicting outcome in patients with resected non-small-cell lung cancer.

    Zhang ZJ, Chen JH, Meng L, Du JJ, Zhang L, Liu Y, Dai HH.

    Chin Med J (Engl). 2007 Jan 20;120(2):125-31.

    PMID:
    17335654
    [PubMed - indexed for MEDLINE]
    Free Article
    20.

    Role of 18F-fluorodeoxyglucose positron emission tomography in predicting epidermal growth factor receptor mutations in non-small cell lung cancer.

    Mak RH, Digumarthy SR, Muzikansky A, Engelman JA, Shepard JA, Choi NC, Sequist LV.

    Oncologist. 2011;16(3):319-26. Epub 2011 Feb 21.

    PMID:
    21339258
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk